The evaluation of approaches to the treatment of myasthenia gravis.
Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment with anticholinesterase inhibitors (AChEIs), immun...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
2019-11-01
|
Series: | Medičnì Perspektivi |
Subjects: | |
Online Access: | http://journals.uran.ua/index.php/2307-0404/article/view/181886 |